Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical Rheumatology, 2026
Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma

Wang H., Yan H., Yang M. et al.

Olink Target 96OncologyImmunological & Inflammatory DiseasesPathophysiologyPlasma

Cardiovascular Research, 2026
miR-146a-5p mediates atherogenic signalling from immune to vascular cells

Climent M., Zani S., Salvarani N. et al.

Olink Target 96 MouseT48 MouseCVDPathophysiologyMouse Serum

HemaSphere, 2026
Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

Diorio C., Myers R., Li Y. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationSerum

Metabolism, 2026
When the proteome meets the metabolome observational and Mendelian randomization analyses

Zheng R., Delgado-Velandia M., Ärnlöv J. et al.

Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

CNS Neuroscience & Therapeutics, 2026
Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via CCR2 / NFκB ‐Mediated Blood–Brain Barrier Disruption

Huang R., Gao L., Dai Y. et al.

Olink Target 96Neurovascular DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

Open Forum Infectious Diseases, 2026
Proteomic Profile After Intervention With Eplerenone Among Persons With HIV

Murthy A., Kolossváry M., Walpert A. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Pulmonology, 2026
Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study

He L., Liu C., Zhao H. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

Circulation: Genomic and Precision Medicine, 2026
Associations of the ICAM1 p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome

Aneja A., Culler K., Ding J. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Frontiers in Immunology, 2026
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia

Wang J., Pan S., Xiong C. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Clinical & Experimental Allergy, 2026
Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

Sun N., Pat Y., Babayev H. et al.

Olink Target 96Environmental Health & ToxicologyNutritional SciencePathophysiologyOrganoid Culture Medium

British Journal of Cancer, 2026
Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer

Rahkola O., Tuomisto A., Elomaa H. et al.

Olink Target 96OncologyPathophysiologyPlasma

Journal of Proteome Research, 2026
Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis

Chu X., Li Y., Wang F. et al.

Olink Target 96Respiratory DiseasesEnvironmental Health & ToxicologyPatient StratificationSerum

Translational Psychiatry, 2026
Plasma proteome profiling identifies novel biomarkers and predictors for schizophrenia

Wu S., Guo X., Jia T. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Aging Cell, 2026
Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease

Tavenier J., Holm N., Kallemose T. et al.

Olink Explore HTAgingPatient StratificationPlasma

Medicine, 2026
Association of genetically determined plasma hepatocyte growth factor with lung cancer and its subtypes: Mendelian randomization and mediation analysis

Xu F., Xu Q., Yu J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Journal of Alzheimer's Disease Reports, 2026
Exploring potential genetic correlation and causality between cathepsins and neurodegenerative diseases: Insight from Mendelian randomization analyses

Shu H., He R., Zhu Z. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Signal Transduction and Targeted Therapy, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation

Lambertucci F., Motiño O., Nogueira-Recalde U. et al.

Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Plasma

European Journal of Applied Physiology, 2026
Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation

Flodin J., Amiri P., Reitzner S. et al.

Olink Target 96Metabolic DiseasesImmunological & Inflammatory DiseasesTechnical EvaluationBlood

Nature Communications, 2026
Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice

He L., Qin X., Ren Q. et al.

Olink Target 48 MouseCVDPathophysiologyMouse Tissue Lysate

The Journal of Headache and Pain, 2026
Plasma proteomics identifies proteins and pathways associated with incident migraine in 50,668 adults

Hong Y., Chen F., Mi Y. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

4146 publications